Comment on: Association Between Glucagon-Like Peptide 1 Receptor Agonists Exposure and Intraocular Pressure Change

被引:0
作者
Tang, Wei-zhen [1 ,2 ]
Chen, Hao-wen [1 ]
Liu, Tai-hang [1 ,2 ]
机构
[1] Chongqing Med Univ, Sch Basic Med Sci, Dept Bioinformat, Chongqing, Peoples R China
[2] Chongqing Med Univ, 1 Yixueyuan Rd,POB 197, Chongqing 400016, Peoples R China
关键词
INDIVIDUALS; GLAUCOMA; RISK;
D O I
10.1016/j.ajo.2024.09.038
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:273 / 274
页数:2
相关论文
共 6 条
[1]   Prescription of glucagon-like peptide 1 agonists and risk of subsequent open-angle glaucoma in individuals with 2 diabetes mellitus [J].
Chuang, Chih-Chu ;
Wang, Kai ;
Chang, Chao-Kai ;
Lee, Chia-Yi ;
Huang, Jing-Yang ;
Wu, Heng-Hsiung ;
Yang, Po-Jen ;
Yang, Shun-Fa .
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2024, 21 (03) :540-546
[2]   Association Between Glucagon-Like Peptide-1 Receptor Agonists Exposure and Intraocular Pressure Change [J].
Hallaj, Shahin ;
Halfpenny, William ;
Chuter, Benton G. ;
Weinreb, Robert N. ;
Baxter, Sally L. ;
Cui, Qi N. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 269 :255-265
[3]   Glucagon-Like Peptide 1 Receptor Agonists - Potential Game Changers in the Treatment of Glaucoma? [J].
Mouhammad, Zaynab Ahmad ;
Vohra, Rupali ;
Horwitz, Anna ;
Thein, Anna-Sophie ;
Rovelt, Jens ;
Cvenkel, Barbara ;
Williams, Pete A. ;
Azuara-Blanco, Augusto ;
Kolko, Miriam .
FRONTIERS IN NEUROSCIENCE, 2022, 16
[4]   Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes [J].
Niazi, Siar ;
Gnesin, Filip ;
Thein, Anna-Sophie ;
Andreasen, Jens R. ;
Horwitz, Anna ;
Mouhammad, Zaynab A. ;
Jawad, Baker N. ;
Niazi, Zia ;
Pourhadi, Nelsan ;
Zareini, Bochra ;
Meaidi, Amani ;
Torp-Pedersen, Christian ;
Kolko, Miriam .
OPHTHALMOLOGY, 2024, 131 (09) :1056-1063
[5]   Model systems for the study of steroid-induced IOP elevation [J].
Rybkin, Ilya ;
Gerometta, Rosana ;
Fridman, Gabrielle ;
Candia, Oscar ;
Danias, John .
EXPERIMENTAL EYE RESEARCH, 2017, 158 :51-58
[6]   Glucagon-like peptide 1 receptor agonist use is associated with reduced risk for glaucoma [J].
Sterling, Jacob ;
Hua, Peiying ;
Dunaief, Joshua L. ;
Cui, Qi N. ;
VanderBeek, Brian L. .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2023, 107 (02) :215-220